VIM and ovarian cancer: Similarly, we observed increased levels of the epithelial marker E-cadherin and reduced amounts of mesenchymal markers, including vimentin and N-cadherin, upon ISL treatment, indicating that ISL at a noncytotoxic concentration led to a robust MET in ovarian cancer cells.